Medical College of Georgia - Cancer Center - Clinical Research

A-Z Index | MCG Home | Site Search

Clinical Trials

Patient receives treatment in Cancer Clinical Research Unit-Jodi with patient

Clinical Trials — Advanced Solid Malignancies

Click on trial for description and contact information.

A Phase I Dose-Escalation, Multi-Center, Open-Label Study of AUY922 Administered I.V. on a Once-Weekly Schedule in Adult Patients with Advanced Solid Malignancies Including Phase II Expansion Arms in Patients with either HER2-Positive or ER-Positive Locally Advanced or Metastatic Breast Cancer

A Phase I Dose-Finding Study of the Anti-Angiogenesis Agent AG-013736, in Combinations of Paclitaxel/Carboplatin, Weekly Paclitaxel, Docetaxel, Capecitabine, and Gemcitabine/Cisplatin in Patients with Advanced Solid Tumors

A Phase I Open-Label, Multi-Center, Parallel Group Study to Assess the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients with and without Impaired Renal Function

FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-small Cell Lung Cancer

A Phase I Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Lipotecan® (TLC388 HCl for Injection) when administered to Patients with Advanced Solid Tumors

Revised October 26, 2009. Please send comments, suggestions or questions about this page to Cancer Team, cancer@mcg.edu.

Clinical Trials

MCG Cancer Center
1410 Laney Walker Blvd.
Augusta, GA 30912

706-721-1663 office
706-721-1670 fax

Cancer Team, cancer@mcg.edu

© 2009 Medical College of Georgia
All rights reserved.